Regulatory RBQM AI driven RBQM and data quality oversight aligned with FDA EMA ICH and MHRA. Supports central and on-site monitoring, medical review, and quality risk management to drive a holistic risk-based strategy for clinical trials. Ideal for sponsors and CROs seeking compliant, efficient data oversight with opportunities to add consulting and implementation services.

Product Expansion MSR software development expands the product portfolio to streamline medical data review. Leadership expansion, including the appointment of a Chief People Officer, signals scale and stronger delivery capabilities for larger engagements. Opportunities to cross-sell with the existing RBQM platform to deliver end-to-end data quality oversight.

Proof of Value Industry recognition including Scrip Award, SCDM Award, and Citeline finalist demonstrates a credible track record and differentiates CluePoints from competitors. These awards provide strong proof points for proposals to sponsors and CROs and can help win larger contracts. Use awards in marketing and sales materials to shorten sales cycles.

Market Adoption The market trend is shifting toward risk-based monitoring and data quality oversight for trials. CluePoints offers a holistic risk-based strategy that can reduce regulatory submission risk and lower trial costs, aligning with sponsor and CRO demand for efficiency and compliance. Position as a partner through long-term engagements and managed services.

Trusted Advisory Beyond software, CluePoints provides thought leadership and consulting to aid risk assessment and solution implementation. This services-led approach enables high-value, long-term engagements and potential for higher ARR when bundled with software licenses. Leverage industry leadership and consulting capabilities to differentiate in competitive bids.